Funding
Launch
Partnership
Acquisition
Policy
Exit & IPO

BeOne Medicine

BeOne Medicine Presents Clinical Data on Zanubrutinib for Elderly Leukemia Patients

June 11, 2026 by Marco Bianchi

BeOne Medicine presented new data on zanubrutinib for treating chronic lymphocytic leukemia or small lymphocytic lymphoma in patients aged 80 and above

Categories Launch Tags BeOne Medicine, Healthtech, Italy Leave a comment

Browse by Country

Latest

BeOne Medicine Presents Clinical Data on Zanubrutinib for Elderly Leukemia PatientsJun 11, 2026

Virgin Mobile Poland Launches New Combined Offer for Phone and Mobile Internet ServicesJun 11, 2026

German AI Startup Unframe Secures $50 Million to Guide Enterprise AI Investment DecisionsJun 11, 2026

Finanza.tech partners with Rainmakers to accelerate startup support across ItalyJun 11, 2026

Spanish robotics startup Theker secures €85m Series A to scale industrial AI deploymentsJun 11, 2026

EU Markets

AI Infrastructure Billions, Banking Consolidation, and a SpaceX IPO Frenzy: What Europe's Financial Markets Mean for Startups This WeekJun 5, 2026

AI, Regulation, and Capital Shifts: What Europe's Financial Markets Mean for Your Startup This WeekMay 29, 2026

AI Debt Warnings, Blockchain Settlements, and Market Volatility: What European Founders Need to Know This WeekMay 23, 2026

Defence Tech Surges, Unicorns Emerge, and Europe's AI Funding Story Keeps Getting BiggerMay 22, 2026

EU Startups News

• About Us • Privacy Policy

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.